Unrecognized myocardial infarction detected by CMR in patients with obesity was associated with a significantly higher risk of MACE (HR 2.86; 95% CI 1.68-4.88; p<0.001).
Cohort (n=1,053)
No
Does the presence of unrecognized myocardial infarction detected by CMR predict MACE in Thai patients with obesity?
Unrecognized myocardial infarction detected by CMR is present in nearly 10% of Thai patients with obesity and is independently associated with a nearly 3-fold increased risk of MACE, providing incremental prognostic value.
Hazard Ratio: 2.86 (95% CI 1.68–4.88)
Absolute Event Rate: 2.58% vs 0.89%
p-value: p=<0.001
Background Unrecognized myocardial infarction (UMI) is associated with adverse outcomes and may occur in patients with obesity, who are at increased cardiovascular risk. Although cardiac magnetic resonance (CMR) enables accurate detection of UMI, prognostic data in patients with obesity remain limited, particularly in Asian populations. This study evaluated the prevalence and prognostic impact of CMR-detected UMI in Thai patients with obesity. Methods This cohort study included 1,053 patients with BMI ≥ 25 kg/m 2 , without a prior diagnosis of myocardial infarction (MI) or coronary revascularization (mean age, 67 ± 11 years; 71.3% grade 1 and 28.7% grade 2 obesity), who underwent CMR at an academic hospital in Thailand between 2014 and 2016. The most common indication was suspected coronary artery disease (78.3%). UMI was identified using late gadolinium enhancement imaging. Patients were followed for major adverse cardiovascular events (MACE), defined as a composite of cardiovascular death, nonfatal MI, or hospitalization for heart failure. Results UMI was identified in 105 patients (9.9%). During a median follow-up of 9.2 (5.2–10.2) years, patients with UMI had a significantly higher rate of MACE compared with those without UMI (2.58 vs. 0.89 per 100 patient-years; HR, 2.86; 95% CI, 1.68–4.88; p 0.05). Conclusions In Thai patients with obesity undergoing CMR, the prevalence of UMI was 9.9% and was independently associated with MACE, providing incremental prognostic value. These findings suggest that CMR-detected UMI may play a role in risk stratification in this population.
Chayanopparat等(Mon,)在肥胖症中进行了一项队列研究(n=1,053)。评估未识别心肌梗死(UMI)与未识别心肌梗死的主要不良心血管事件(MACE),定义为心血管死亡、非致命心肌梗死或因心力衰竭住院的复合指标(HR 2.86,95% CI 1.68-4.88,p=<0.001)。在肥胖患者中,通过CMR检测的未识别心肌梗死与MACE的显著更高风险相关(HR 2.86;95% CI 1.68-4.88;p<0.001)。
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: